Santoke has many decades of experience in market access and reimbursement for medicinal products. He joined IGES in 2022, prior to this he was General Manager of Pierre Fabre Pharmaceuticals UK and a senior consultant to the ABPI (Association of the British Pharmaceutical Industry) responsible for negotiating the Voluntary Scheme for Branded Medicines Pricing and Access (VPAS). He studied biochemistry at the University of Leeds. His work focuses on policy and reimbursement of innovative therapies in the European Union and the United Kingdom.